The company recently transitioned from packaging the concentrate in glass vials to plastic bags.
ISMP said several pharmacists and pharmacy technicians have expressed concerns about the potential risk of mixing up the concentrate with other intravenous infusion bags, as the new packaging features similar labeling to other IV products.
“The potassium chloride for injection in the bag is highly concentrated and can stop a patient’s heart if accidentally administered undiluted, resulting in a fatal outcome,” ISMP said.
Healthcare facilities that opt to use this product should take measures to prevent potentially fatal medication errors, the group said. Such actions include immediately placing warning labels on the product once unpackaged from its box and allowing only the pharmacy to store and use the product, which is intended to be diluted with IV fluid.
View ISMP’s full alert here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
